Product Information
SAVELLA TITRATION PACK is a brand product labeled by Allergan, Inc., priced at $8.1414 per EA under NDC 00456150055. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jan 14, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Allergan, Inc.NDC
00456150055
Classification
Brand
Dosage Form
KIT
Route
ORAL
Effective Date
9/23/2026
Approval Type
New Drug (NDA)
FDA Application
NDA022256FDA Approved
1/14/2009
TE Code
AB
On Market Since
4/17/2009
Price Statistics
The NADAC for SAVELLA TITRATION PACK has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 192.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.1414 per EA |
|---|---|
| All-time high | $8.1909 (May 14, 2025) |
| All-time low | $2.7792 (Nov 28, 2013) |
| 52-week high | $8.1644 |
| 52-week low | $8.1386 |
| Median price | $6.3846 |
| Average price | $6.0610 |
| Largest weekly change | +9.9% (Oct 7, 2015) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the milnacipran hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
milnacipran hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SAVELLA TITRATION PACK?
The current National Average Drug Acquisition Cost (NADAC) for SAVELLA TITRATION PACK, manufactured by Allergan, Inc., is $8.1414 per EA (NDC 00456150055), effective Sep 30, 2026.
How has the price of SAVELLA TITRATION PACK changed over time?
Over the history we have for it, the NADAC for SAVELLA TITRATION PACK has risen 192.9%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SAVELLA TITRATION PACK?
Since Nov 28, 2013, the NADAC for SAVELLA TITRATION PACK has ranged from a low of $2.7792 (Nov 28, 2013) to a high of $8.1909 (May 14, 2025), with a median of $6.3846 per EA.
Are there cheaper alternatives to SAVELLA TITRATION PACK?
No other NADAC-published product currently shares the active ingredient and strength of SAVELLA TITRATION PACK in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SAVELLA TITRATION PACK?
SAVELLA TITRATION PACK (NDC 00456150055) is labeled by Allergan, Inc., and CMS classifies it as a brand product.